Web Stats Provided By Google Analytics

Tuesday, May 7, 2013

More on Eli Lilly and ObamaCare...

Eli Lilly CEO Dr. John Lechleiter Says Obama Administration "Dual-Eligibles" Rebate Plan Would Lead to "Catastrophic Consequences" for Innovation Industry Could Face More than $100 Billion in Extra Costs Under President's Plan, Lechleiter Says, in Response to Questioning from National Center for Public Policy Research Patients with Private ... (more)

http://www.nationalcenter.org/PR-Eli_Lilly_050713.html

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts